The University of North Carolina at Chapel Hill and the pharmaceutical company GSK (GlaxoSmithKline) are today announcing an unusually close collaboration in an effort to find a cure for HIV. The company will provide $4 million a year for five years to support a new research center focused on developing a cure for HIV. In addition, the company will locate some researchers at Chapel Hill for the project. UNC and the company will also create a new company, Qura Therapeutics, that will manage intellectual property and commercialization of any discoveries from the collaboration.
